Ultrasensitive detection of circulating tumour DNA enriches for patients with a greater risk of recurrence of clinically localised prostate cancer
Authors
Pope, B.Park, G.
Lau, E.
Belic, J.
Lach, R.
George, A.
McCoy, P.
Nguyen, A.
Grima, C.
Campbell, B.
Jung, C. H.
Ditter, E. J.
Zhao, H.
Wedge, David C
Brewer, D. S.
Lynch, A. G.
Dev, H.
Gnanpragasam, V. J.
Rosenfeld, N.
Hovens, C. M.
Corcoran, N. M.
Massie, C. E.
Affiliation
Manchester Cancer Research Centre, University of Manchester, Manchester, UK.Issue Date
2024
Metadata
Show full item recordCitation
Pope B, Park G, Lau E, Belic J, Lach R, George A, et al. Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer. Eur Urol. 2024 Apr;85(4):407-10. PubMed PMID: 38378299. Epub 2024/02/21. eng.Journal
European UrologyDOI
10.1016/j.eururo.2024.01.002PubMed ID
38378299Additional Links
https://dx.doi.org/10.1016/j.eururo.2024.01.002Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.eururo.2024.01.002
Scopus Count
Collections
Related articles
- Ultrasensitive prostate specific antigen after prostatectomy reliably identifies patients requiring postoperative radiotherapy.
- Authors: Kang JJ, Reiter RE, Steinberg ML, King CR
- Issue date: 2015 May
- Prostate specific antigen in screening for recurrence following radical prostatectomy for localised prostatic cancer.
- Authors: Bentvelsen FM, van den Ouden D, Schröder FH
- Issue date: 1993 Jul
- Ultrasensitive prostate specific antigen and its role after radical prostatectomy: a systematic review.
- Authors: Tilki D, Kim SI, Hu B, Dall'Era MA, Evans CP
- Issue date: 2015 May
- Association between Postoperative Detection of Circulating Tumor Cells and Recurrence in Patients with Prostate Cancer.
- Authors: Pak S, Suh YS, Lee DE, Kim SH, Joung JY, Park WS, Lee SJ, Lee KH
- Issue date: 2020 Jun
- Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy.
- Authors: Giesing M, Suchy B, Driesel G, Molitor D
- Issue date: 2010 Apr